Cape Investment Advisory »

Revance Therapeutics shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9k 447 8.79
2023-09-30 $5.1k 447 11.47
2023-06-30 $22k 877 25.31
2023-03-31 $28k 877 32.21